| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cardiff Oncology, Inc. | Director | Stock Options | 128K | $333K | $2.60 | Jun 27, 2024 | Direct |
| CytomX Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 38K | May 15, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CRDF | Cardiff Oncology, Inc. | Jun 27, 2024 | 1 | $0 | 4 | Jul 1, 2024 | Director |
| CTMX | CytomX Therapeutics, Inc. | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
| CRDF | Cardiff Oncology, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
| CTMX | CytomX Therapeutics, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
| CTMX | CytomX Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| CRDF | Cardiff Oncology, Inc. | Mar 9, 2022 | 1 | $0 | 4 | Mar 10, 2022 | Director |
| CTMX | CytomX Therapeutics, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |
| CRDF | Cardiff Oncology, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |
| CRDF | Cardiff Oncology, Inc. | Jun 10, 2021 | 0 | $0 | 3 | Jun 14, 2021 | Director |